Beta-1,3/1,6-D-Glucan Ganoderma Lucidum

Beta-1,3/1,6-D-Glucan · Ganoderma Lucidum (Fakultas Kedokteran Universitas Indonesia)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Beta-1,3/1,6-D-Glucan Ganoderma Lucidum, covering 2019-08-02 to 2021-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis [Phase 2, Phase 3]